Shin Tsunekawa to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications Shin Tsunekawa has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.015
-
Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes: metabolic and antiatherogenic consequences. Diabetes Care. 2005 Mar; 28(3):757-8.
Score: 0.015